Stock data
Ionis Pharmaceuticals, Inc. (IONS)
Ionis Pharmaceuticals, Inc. (IONS) reported revenue of US$943.71M and net income of -US$381.39M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$943.71M | — | -US$381.68M | -US$381.39M | — |
| 2024 | US$705.14M | — | -US$475.08M | -US$453.90M | — |
| 2023 | US$787.65M | — | -US$353.73M | -US$366.29M | — |
| 2022 | US$587.37M | — | -US$410.19M | -US$269.72M | — |
| 2021 | US$810.46M | — | -US$30.19M | -US$28.60M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$267.95M | -US$114.65M | — |
| 2026-03-31 | US$246.09M | -US$92.53M | — |
| 2025-12-31 | US$203.33M | -US$229.39M | — |
| 2025-09-30 | US$156.72M | -US$128.61M | — |
| 2025-06-30 | US$452.05M | US$123.55M | — |
| 2025-03-31 | US$131.61M | -US$146.94M | — |
| 2024-12-31 | US$226.58M | -US$104.35M | — |
| 2024-09-30 | US$133.81M | -US$140.48M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.